1. EachPod
EachPod

The Future of Biotech Marketing is Personality-Driven

Author
Chris Conner
Published
Wed 03 Sep 2025
Episode Link
https://cclifescience.substack.com/p/the-future-of-biotech-marketing

Anis Fahandej-Sadi is building two businesses. He is the founder of TLDR Biotech, a daily newsletter that condenses life science news into a quick, skimmable format, and creator of Science 2 Sales, a service designed to help biotech companies accelerate business development. In this conversation, Anis opens up about his career journey, the lessons he’s learned in building content-driven businesses, and his perspective on where life science marketing is heading.

The Birth of TLDR Biotech

Anis started TLDR Biotech with this idea: build the thing you wish existed. With his background in sales and BD, he saw how overwhelming it was to track 10+ news sources every day just to stay informed. So he created a newsletter that captures the good, the bad, and the ugly (those are literally the categories) in biotech news, sprinkled with memes and GIFs for personality.

The format drove strong reactions. Some folks loved the humor, but hated the GIFs. However, strong reactions mean you’re creating something memorable. Strive to make a product where you can say, “It’s not for everybody.” Nevertheless, growth stalled early on, leading Anis to pause the newsletter and retool his approach.

Anis shared his struggles around finding product-market fit, admitting he initially took the wrong approach by treating it as a full-time venture too early. He had to find the product that suited him. After a strategic pause in May, he restructured the backend to create content more efficiently while maintaining quality. Now he is focused on organic growth through LinkedIn and expanding into interview content to expand his reach.

From Chemistry to Business Development

After earning a master’s in chemistry, he taught English in Korea, then pivoted into sales roles for life science companies like Cytiva and OmniaBio. Business development roles are a great fit for scientists who crave variety and human interaction, but the transition isn’t easy. There’s often little formal training, so one has to learn prospecting, discovery calls, and pipeline management on the fly. His advice for scientists considering sales: leverage LinkedIn, embrace continuous learning, and be clear on why you want to leave the lab.

Science to Sales: A New Kind of BD Support

His current venture, Science to Sales, tackles the pain of BD reps spending too much time on cold outreach instead of moving real deals forward. His team takes on prospecting, cold emails, LinkedIn outreach, and calls, so client BD teams can focus on high-value work. The approach begins with deep research into the client’s ideal customer profile, growth goals, and messaging. But the most interesting angle is pairing outbound prospecting with executive-driven LinkedIn content. The platform is evolving beyond corporate messaging to more authentic, personal storytelling.

Why LinkedIn Needs Personality

The old model of corporate-only content is dead. The future is personality-driven, with executives and BD reps building authentic, active profiles. He points to examples like Steve Harvey of Camena Biosciences and Philippe Baaske at NanoTemper as models for how thought leadership and “building in public” can humanize companies and create inbound traction. As a clear signal of where the market is going, even companies like PayPal are hiring full-time staff to manage CEO content.

Short-form video and personality-driven LinkedIn posts are no longer optional. They’re becoming essential. And while it’s not easy (Anis admits to his own hesitations about video), the payoff is familiarity that turns cold calls into warm conversations.

Your deepest insights are your best branding. I’d love to help you share them. Chat with me about custom content for your life science brand. Or visit my website.



This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit cclifescience.substack.com

Share to: